Impact of microRNAs on regulatory networks and pathways in human colorectal carcinogenesis and development of metastasis

BMC Genomics

Volumn 14, Issue 1, 2013, Pages

  Pizzini, Silvia ^a   Bisognin, Andrea ^a   Mandruzzato, Susanna ^a,b   Biasiolo, Marta ^a   Facciolli, Arianna ^a   Perilli, Lisa ^a   Rossi, Elisabetta ^a   Esposito, Giovanni ^b   Rugge, Massimo ^a   Pilati, Pierluigi ^a   Mocellin, Simone ^a   Nitti, Donato ^a   Bortoluzzi, Stefania ^a   Zanovello, Paola ^a,b  

^a UNIVERSITY OF PADOVA   (Italy)

^b VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

Author keywords

Colorectal cancer; Gene expression; Metastasis; microRNA; Regulatory networks

Indexed keywords

MICRORNA; MICRORNA 10B; MICRORNA 146A; MICRORNA 150; MICRORNA 182; MICRORNA 201; MICRORNA 210; MICRORNA 708; UNCLASSIFIED DRUG; ENTPD5 PROTEIN, HUMAN; INORGANIC PYROPHOSPHATASE; MIRN10 MICRORNA, HUMAN; MIRN182 MICRORNA, HUMAN; ONCOPROTEIN; TRANSCRIPTOME;

ADULT; ARTICLE; CANCER SURVIVAL; CARCINOGENESIS; CLINICAL ARTICLE; COLON MUCOSA; COLORECTAL CARCINOMA; CONTROLLED STUDY; EMBRYO; ENTPD5 GENE; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER METASTASIS; MALE; TUMOR GROWTH; UPREGULATION; ADENOCARCINOMA; AGED; COLORECTAL TUMOR; DISEASE COURSE; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETICS; KAPLAN MEIER METHOD; LIVER TUMOR; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; RNA INTERFERENCE; SECONDARY;

ADENOCARCINOMA; AGED; CARCINOGENESIS; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; ONCOGENE PROTEINS; PYROPHOSPHATASES; RNA INTERFERENCE; TRANSCRIPTOME;

EID: 84883094004     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-14-589     Document Type: Article

References (52)

1. Negrini M, Nicoloso MS, Calin GA. MicroRNAs and cancer-new paradigms in molecular oncology. Curr Opin Cell Biol 2009, 21(3):470-479. 10.1016/j.ceb.2009.03.002, 19411171.
2. Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006, 6(4):259-269.
3. Nicoloso MS, Spizzo R, Shimizu M, Rossi S, Calin GA. MicroRNAs-the micro steering wheel of tumour metastases. Nat Rev Cancer 2009, 9(4):293-302.
4. Slaby O, Svoboda M, Michalek J, Vyzula R. MicroRNAs in colorectal cancer: translation of molecular biology into clinical application. Mol Cancer 2009, 8:102. 10.1186/1476-4598-8-102, 2780389, 19912656.
5. de Krijger I, Mekenkamp LJ, Punt CJ, Nagtegaal ID. MicroRNAs in colorectal cancer metastasis. J Pathol 2011, 224(4):438-447. 10.1002/path.2922, 21706478.
6. Hurst DR, Edmonds MD, Welch DR. Metastamir: the field of metastasis-regulatory microRNA is spreading. Cancer Res 2009, 69(19):7495-7498. 10.1158/0008-5472.CAN-09-2111, 2756311, 19773429.
7. Bullock MD, Sayan AE, Packham GK, Mirnezami AH. MicroRNAs: critical regulators of epithelial to mesenchymal (EMT) and mesenchymal to epithelial transition (MET) in cancer progression. Biol Cell 2012, 104(1):3-12. 10.1111/boc.201100115, 22188537.
8. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61(2):69-90. 10.3322/caac.20107, 21296855.
9. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013, 63(1):11-30. 10.3322/caac.21166, 23335087.
10. Fritzmann J, Morkel M, Besser D, Budczies J, Kosel F, Brembeck FH, Stein U, Fichtner I, Schlag PM, Birchmeier W. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential. Gastroenterology 2009, 137(1):165-175. 10.1053/j.gastro.2009.03.041, 19328798.
11. Agostini M, Pucciarelli S, Calore F, Bedin C, Enzo M, Nitti D. MiRNAs in colon and rectal cancer: a consensus for their true clinical value. Clin Chim Acta 2010, 411(17-18):1181-1186.
12. Liu M, Chen H. The role of microRNAs in colorectal cancer. J Genet Genomics 2010, 37(6):347-358. 10.1016/S1673-8527(09)60053-9, 20621017.
13. Schee K, Fodstad O, Flatmark K. MicroRNAs as biomarkers in colorectal cancer. Am J Pathol 2010, 177(4):1592-1599. 10.2353/ajpath.2010.100024, 2947254, 20829435.
14. Kulda V, Pesta M, Topolcan O, Liska V, Treska V, Sutnar A, Rupert K, Ludvikova M, Babuska V, Holubec L, et al. Relevance of miR-21 and miR-143 expression in tissue samples of colorectal carcinoma and its liver metastases. Cancer Genet Cytogenet 2010, 200(2):154-160. 10.1016/j.cancergencyto.2010.04.015, 20620599.
15. Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED, Yanaihara N, Yuen ST, Chan TL, Kwong DL, Au GK, et al. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 2008, 299(4):425-436. 10.1001/jama.299.4.425, 2614237, 18230780.
16. Yang CS, Rana TM. Learning the molecular mechanisms of the reprogramming factors: let's start from microRNAs. Mol bioSyst 2013, 9(1):10-17. 10.1039/c2mb25088h, 23037570.
17. Tsai YP, Wu KJ. Hypoxia-regulated target genes implicated in tumor metastasis. J Biomed Sci 2012, 19:102. 10.1186/1423-0127-19-102, 3541338, 23241400.
18. Saini S, Yamamura S, Majid S, Shahryari V, Hirata H, Tanaka Y, Dahiya R. MicroRNA-708 induces apoptosis and suppresses tumorigenicity in renal cancer cells. Cancer Res 2011, 71(19):6208-6219. 10.1158/0008-5472.CAN-11-0073, 21852381.
19. Lionetti M, Biasiolo M, Agnelli L, Todoerti K, Mosca L, Fabris S, Sales G, Deliliers GL, Bicciato S, Lombardi L, et al. Identification of microRNA expression patterns and definition of a microRNA/mRNA regulatory network in distinct molecular groups of multiple myeloma. Blood 2009, 114(25):e20-e26. 10.1182/blood-2009-08-237495, 19846888.
20. Sales G, Coppe A, Bisognin A, Biasiolo M, Bortoluzzi S, Romualdi C. MAGIA, a web-based tool for miRNA and genes integrated analysis. Nucleic Acids Res 2010, 38(Web Server issue):W352-W359. 2896126, 20484379.
21. Mikula M, Rubel T, Karczmarski J, Goryca K, Dadlez M, Ostrowski J. Integrating proteomic and transcriptomic high-throughput surveys for search of new biomarkers of colon tumors. Funct Integr Genomics 2010, 11(2):215-224.
22. Chai G, Liu N, Ma J, Li H, Oblinger JL, Prahalad AK, Gong M, Chang LS, Wallace M, Muir D, et al. MicroRNA-10b regulates tumorigenesis in neurofibromatosis type 1. Cancer Sci 2010, 101(9):1997-2004. 10.1111/j.1349-7006.2010.01616.x, 20550523.
23. Bisognin A, Sales G, Coppe A, Bortoluzzi S, Romualdi C. MAGIA(2): from miRNA and genes expression data integrative analysis to microRNA-transcription factor mixed regulatory circuits (2012 update). Nucleic Acids Res 2012, 40(Web Server issue):W13-W21. 3394337, 22618880.
24. Luo X, Burwinkel B, Tao S, Brenner H. MicroRNA signatures: novel biomarker for colorectal cancer?. Cancer Epidemiol Biomarkers Prev 2011, 20(7):1272-1286. 10.1158/1055-9965.EPI-11-0035, 21551242.
25. Farazi TA, Spitzer JI, Morozov P, Tuschl T. miRNAs in human cancer. J Pathol 2011, 223(2):102-115. 10.1002/path.2806, 3069496, 21125669.
26. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, et al. MicroRNA expression profiles classify human cancers. Nature 2005, 435(7043):834-838. 10.1038/nature03702, 15944708.
27. Martello G, Rosato A, Ferrari F, Manfrin A, Cordenonsi M, Dupont S, Enzo E, Guzzardo V, Rondina M, Spruce T, et al. A MicroRNA targeting dicer for metastasis control. Cell 2010, 141(7):1195-1207. 10.1016/j.cell.2010.05.017, 20603000.
28. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006, 103(7):2257-2261. 10.1073/pnas.0510565103, 1413718, 16461460.
29. Chang KH, Miller N, Kheirelseid EA, Lemetre C, Ball GR, Smith MJ, Regan M, McAnena OJ, Kerin MJ. MicroRNA signature analysis in colorectal cancer: identification of expression profiles in stage II tumors associated with aggressive disease. Int J Colorectal Dis 2011, 26(11):1415-1422. 10.1007/s00384-011-1279-4, 21739196.
30. Oberg AL, French AJ, Sarver AL, Subramanian S, Morlan BW, Riska SM, Borralho PM, Cunningham JM, Boardman LA, Wang L, et al. miRNA expression in colon polyps provides evidence for a multihit model of colon cancer. PloS one 2011, 6(6):e20465. 10.1371/journal.pone.0020465, 3111419, 21694772.
31. Negrini M, Calin GA. Breast cancer metastasis: a microRNA story. Breast Cancer Res 2008, 10(2):203. 10.1186/bcr1867, 2397516, 18373886.
32. Tian Y, Luo A, Cai Y, Su Q, Ding F, Chen H, Liu Z. MicroRNA-10b promotes migration and invasion through KLF4 in human esophageal cancer cell lines. J Biol Chem 2010, 285(11):7986-7994. 10.1074/jbc.M109.062877, 2832949, 20075075.
33. Kim K, Lee HC, Park JL, Kim M, Kim SY, Noh SM, Song KS, Kim JC, Kim YS. Epigenetic regulation of microRNA-10b and targeting of oncogenic MAPRE1 in gastric cancer. Epigenetics 2011, 6(6):740-751. 10.4161/epi.6.6.15874, 21562367.
34. Shen X, Fang J, Lv X, Pei Z, Wang Y, Jiang S, Ding K. Heparin impairs angiogenesis through inhibition of microRNA-10b. J Biol Chem 2011, 286(30):26616-26627. 10.1074/jbc.M111.224212, 3143626, 21642433.
35. Ibrahim SA, Yip GW, Stock C, Pan JW, Neubauer C, Poeter M, Pupjalis D, Koo CY, Kelsch R, Schule R, et al. Targeting of syndecan-1 by microRNA miR-10b promotes breast cancer cell motility and invasiveness via a Rho-GTPase- and E-cadherin-dependent mechanism. Int J Cancer 2012, 131(6):E884-E896. 10.1002/ijc.27629, 22573479.
36. Tsukerman P, Stern-Ginossar N, Gur C, Glasner A, Nachmani D, Bauman Y, Yamin R, Vitenshtein A, Stanietsky N, Bar-Mag T, et al. MiR-10b downregulates the stress-induced cell surface molecule MICB, a critical ligand for cancer cell recognition by natural killer cells. Cancer Res 2012, 72(21):5463-5472. 10.1158/0008-5472.CAN-11-2671, 22915757.
37. Liu Z, Zhu J, Cao H, Ren H, Fang X. miR-10b promotes cell invasion through RhoC-AKT signaling pathway by targeting HOXD10 in gastric cancer. Int J Oncol 2012, 40(5):1553-1560.
38. Liu B, Zhang J, Huang C, Liu H. Dyskerin overexpression in human hepatocellular carcinoma is associated with advanced clinical stage and poor patient prognosis. PloS one 2012, 7(8):e43147. 10.1371/journal.pone.0043147, 3418259, 22912812.
39. Sun L, Yan W, Wang Y, Sun G, Luo H, Zhang J, Wang X, You Y, Yang Z, Liu N. MicroRNA-10b induces glioma cell invasion by modulating MMP-14 and uPAR expression via HOXD10. Brain Res 2011, 1389:9-18.
40. Li G, Wu Z, Peng Y, Liu X, Lu J, Wang L, Pan Q, He ML, Li XP. MicroRNA-10b induced by Epstein-Barr virus-encoded latent membrane protein-1 promotes the metastasis of human nasopharyngeal carcinoma cells. Cancer Lett 2010, 299(1):29-36. 10.1016/j.canlet.2010.07.021, 20732742.
41. Ma L, Teruya-Feldstein J, Weinberg RA. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 2007, 449(7163):682-688. 10.1038/nature06174, 17898713.
42. Nakata K, Ohuchida K, Mizumoto K, Kayashima T, Ikenaga N, Sakai H, Lin C, Fujita H, Otsuka T, Aishima S, et al. MicroRNA-10b is overexpressed in pancreatic cancer, promotes its invasiveness, and correlates with a poor prognosis. Surgery 2011, 150(5):916-922. 10.1016/j.surg.2011.06.017, 22018284.
43. Preis M, Gardner TB, Gordon SR, Pipas JM, Mackenzie TA, Klein EE, Longnecker DS, Gutmann EJ, Sempere LF, Korc M. MicroRNA-10b expression correlates with response to neoadjuvant therapy and survival in pancreatic ductal adenocarcinoma. Clin Cancer Res 2011, 17(17):5812-5821. 10.1158/1078-0432.CCR-11-0695, 3167031, 21652542.
44. Roth C, Rack B, Muller V, Janni W, Pantel K, Schwarzenbach H. Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer. Breast Cancer Res 2010, 12(6):R90. 10.1186/bcr2766, 3046429, 21047409.
45. Sasayama T, Nishihara M, Kondoh T, Hosoda K, Kohmura E. MicroRNA-10b is overexpressed in malignant glioma and associated with tumor invasive factors, uPAR and RhoC. Int J Cancer 2009, 125(6):1407-1413. 10.1002/ijc.24522, 19536818.
46. Chang KH, Miller N, Kheirelseid EA, Ingoldsby H, Hennessy E, Curran CE, Curran S, Smith MJ, Regan M, McAnena OJ, et al. MicroRNA-21 and PDCD4 expression in colorectal cancer. Eur J Surg Oncol 2011, 37(7):597-603. 10.1016/j.ejso.2011.04.001, 21546206.
47. Stella J, Bavaresco L, Braganhol E, Rockenbach L, Farias PF, Wink MR, Azambuja AA, Barrios CH, Morrone FB, Oliveira Battastini AM. Differential ectonucleotidase expression in human bladder cancer cell lines. Urol Oncol 2010, 28(3):260-267. 10.1016/j.urolonc.2009.01.035, 19372055.
48. Knobel PA, Kotov IN, Felley-Bosco E, Stahel RA, Marti TM. Inhibition of REV3 expression induces persistent DNA damage and growth arrest in cancer cells. Neoplasia 2011, 13(10):961-970. 3201572, 22028621.
49. Sellak H, Wu S, Lincoln TM. KLF4 and SOX9 transcription factors antagonize beta-catenin and inhibit TCF-activity in cancer cells. Biochimica et biophysica acta 2012, 1823(10):1666-1675. 10.1016/j.bbamcr.2012.06.027, 22766303.
50. Betel D, Koppal A, Agius P, Sander C, Leslie C. Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites. Genome Biol 2010, 11(8):R90. 10.1186/gb-2010-11-8-r90, 2945792, 20799968.
51. Luo W, Friedman MS, Shedden K, Hankenson KD, Woolf PJ. GAGE: generally applicable gene set enrichment for pathway analysis. BMC Bioinform 2009, 10:161.
52. Ghisi M, Corradin A, Basso K, Frasson C, Serafin V, Mukherjee S, Mussolin L, Ruggero K, Bonanno L, Guffanti A, et al. Modulation of microRNA expression in human T-cell development: targeting of NOTCH3 by miR-150. Blood 2011, 117(26):7053-7062. 10.1182/blood-2010-12-326629, 21551231.